| ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
AKAP1 |
AKAP1, AKAP149, PRKA1: A kinase anchor protein 1, mitochondrial precursor |
0.347 |
Evidence |
|
| ARFGAP1 |
IPI00175169 |
GGA3 |
GGA3, KIAA0154: ADP-ribosylation factor-binding protein GGA3 |
0.347 |
Evidence |
|
| RAVER1 |
RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 |
DSG2 |
DSG2: Desmoglein-2 precursor |
0.347 |
Evidence |
|
| YWHAG |
YWHAG: 14-3-3 protein gamma |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
0.347 |
Evidence |
|
| HSPE1 |
HSPE1: 10 kDa heat shock protein, mitochondrial |
YWHAG |
YWHAG: 14-3-3 protein gamma |
0.347 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BCAP31 |
BCAP31, BAP31, DXS1357E: B-cell receptor-associated protein 31 |
0.347 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
0.347 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
RAVER1 |
RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 |
0.347 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
ADAM33 |
ADAM33, UNQ873/PRO1891: ADAM 33 precursor |
0.347 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
0.347 |
Evidence |
|
| SLC4A3 |
SLC4A3, AE3: Anion exchange protein 3 |
FZR1 |
IPI00099464 |
0.347 |
Evidence |
|
| SLC4A3 |
SLC4A3, AE3: Anion exchange protein 3 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
0.347 |
Evidence |
|
| MAP2K3 |
IPI00218858 |
FGF23 |
FGF23, HYPF, UNQ3027/PRO9828: Fibroblast growth factor 23 precursor |
0.347 |
Evidence |
|
| GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.347 |
Evidence |
|
| GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
C1QTNF4 |
C1QTNF4, CTRP4: Complement C1q tumor necrosis factor-related protein 4 precursor |
0.347 |
Evidence |
|
| NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.347 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
DDX20 |
DDX20, DP103, GEMIN3: Probable ATP-dependent RNA helicase DDX20 |
0.347 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
RAVER1 |
RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 |
0.347 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
NME3 |
NME3: Nucleoside diphosphate kinase 3 |
0.347 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
ARHGEF12 |
ARHGEF12, KIAA0382, LARG: Rho guanine nucleotide exchange factor 12 |
0.347 |
Evidence |
|
| CTSE |
CTSE: Cathepsin E precursor |
CST5 |
CST5: Cystatin-D precursor |
0.347 |
Evidence |
|
| BMP1 |
IPI00009054 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
0.347 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.347 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
SLC9A3R2 |
SLC9A3R2: SLC9A3R2 protein (Fragment) |
0.347 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
PTBP1 |
PTBP1: Polypyrimidine tract binding protein 1 |
0.347 |
Evidence |
|